Ítem
Acceso Abierto
Desenlaces materno-fetales en pacientes gestantes con infección confirmada por SARS COV 2 - Hospital Universitario Mayor, marzo 2020 - 2021
dc.contributor.advisor | Gómez Polanía, Leonardo | |
dc.contributor.advisor | Buitrago Medina, Daniel Alejandro | |
dc.creator | Rodríguez Siachoque, Melissa | |
dc.creator.degree | Especialista en Ginecología y Obstericia | es |
dc.creator.degreeLevel | Maestría | |
dc.creator.degreetype | Full time | es |
dc.date.accessioned | 2022-02-07T14:00:10Z | |
dc.date.available | 2022-02-07T14:00:10Z | |
dc.date.created | 2022-01-24 | |
dc.description | La infección por SARS CoV-2 es de reciente aparición con gran impacto a nivel mundial, reconocida inicialmente por su severidad, alta tasa de contagio y mortalidad a corto plazo. El diagnóstico en la población gestante, así como el pronóstico y los desenlaces maternos y fetales han sido motivo de discusión debido a los cambios fisiológicos del embarazo que muchas veces pueden enmascarar los síntomas de la enfermedad. Considerando que la población gestante se encuentra dentro del grupo de pacientes con riesgo aumentado es importante describir los desenlaces materno-fetales en pacientes con infección confirmada por SARS CoV-2 en el Hospital Universitario Mayor Méderi durante marzo del año 2020 – 2021. | es |
dc.description.abstract | SARS CoV-2 infection is of recent appearance with great impact worldwide, initially recognized for its severity, high rate of contagion and short-term mortality. The diagnosis in the pregnant population, as well as the prognosis and maternal and fetal outcomes have been the subject of discussion due to the physiological changes of pregnancy that can often mask the symptoms of the disease. Considering that the pregnant population is within the group of patients with increased risk, it is important to describe the maternal-fetal outcomes in patients with confirmed SARS CoV-2 infection at the Hospital Universitario Mayor Méderi during March 2020-2021. | es |
dc.format.extent | 43 pp | es |
dc.format.mimetype | application/pdf | es |
dc.identifier.doi | https://doi.org/10.48713/10336_33578 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/33578 | |
dc.language.iso | spa | es |
dc.publisher | Universidad del Rosario | |
dc.publisher.department | Escuela de Medicina y Ciencias de la Salud | |
dc.publisher.program | Especialización en Ginecología y Obstericia | |
dc.rights | Atribución-CompartirIgual 2.5 Colombia | * |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | es |
dc.rights.acceso | Abierto (Texto Completo) | es |
dc.rights.licencia | EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos. | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-sa/2.5/co/ | * |
dc.source.bibliographicCitation | Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. | es |
dc.source.bibliographicCitation | 2. WHO, W. H. O. (2020). Situation Report - 65 - Coronavirus disease 2019. World Health Organization, 2019(March), 2633. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 | es |
dc.source.bibliographicCitation | 3. Ridenhour, B., Kowalik, J. M., & Shay, D. K. (2018). Unraveling R0: Considerations for public health applications. American Journal of Public Health, 108, S445–S454. | es |
dc.source.bibliographicCitation | 4. Peng YD, Meng K, Guan HQ, et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Mar 2. 2020. p. 48 | es |
dc.source.bibliographicCitation | Tang, Y.-W. infecto. pd., Schmitz, J. E., Persing, D. H., & Stratton, C. W. (2020). The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges. Journal of Clinical Microbiology | es |
dc.source.bibliographicCitation | Yu, N., Li, W., Kang, Q., Xiong, Z., Wang, S., Lin, X., Liu, Y., Xiao, J., Liu, H., Deng, D., Chen, S., Zeng, W., Feng, L., & Wu, J. (2020). Clinical features and obstetric and neonatal outcomes | es |
dc.source.bibliographicCitation | 7. https://saludata.saludcapital.gov.co/osb/index.php/datos-de-salud/enfermedades-trasmisibles/covid19/ | es |
dc.source.bibliographicCitation | Di Mascio, D., Khalil, A., Saccone, G., Rizzo, G., Buca, D., Liberati, M., … D’Antonio, F. | es |
dc.source.bibliographicCitation | (2020). Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM, 100107. doi:10.1016/j.ajogmf.2020.100107 | es |
dc.source.bibliographicCitation | Castro P, Matos AP, Werner H, et al. Covid-19 and Pregnancy: An Overview. Rev Bras Ginecol Obstet 2020;42(7):420–426 | es |
dc.source.bibliographicCitation | Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5(4):536-544 | es |
dc.source.bibliographicCitation | Xiaowei L, Manman G, Yizhao P, et al. Molecular immune pathogenesis and diagnosis of COVID-19, J Pharm Anal 2020;10(2):102-108. / 5. Meyerowitz EA, Richterman A, Gandhi RT, et al. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann Intern Med 2020;1-12. | es |
dc.source.bibliographicCitation | https://coronavirus.jhu.edu/map.html | es |
dc.source.bibliographicCitation | Kimberlin D, Stagno S. Can SARS-CoV-19 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed | es |
dc.source.bibliographicCitation | Zeng L, Xia S, Yuan W, et al. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA Pediatr 2020;174(7):722-725 | es |
dc.source.bibliographicCitation | Alzamora MC, Paredes T, Caceres D, et al. Severe COVID-19 during pregnancy and Posible Vertical Transmission. Am J Perinatol 2020;37(8):861-865. | es |
dc.source.bibliographicCitation | Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 2020;172:577-582. | es |
dc.source.bibliographicCitation | 18. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hopitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061-1069. | es |
dc.source.bibliographicCitation | Rijkers G, Murk JL, Wintermans B, et al. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections. J Infect Dis 2020;222(8):1265-1269.) | es |
dc.source.bibliographicCitation | Honein MA, Christie A, Rose DA, et al. Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020. Morb Mortal Wkly Rep 2020;69(49):1860-1867 | es |
dc.source.bibliographicCitation | Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:1-14. | es |
dc.source.bibliographicCitation | Yanes-Lane M, Winters N, Fregonese F, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis. Plos One 2020;15(11):1-21 | es |
dc.source.bibliographicCitation | Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. Morb Mortal Wkly Rep 2020;69(44):1641-1647 | es |
dc.source.bibliographicCitation | Dashraath P, Wong JL, Lim MX, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. AJOG 2020;222(6):521-531. | es |
dc.source.bibliographicCitation | Collin J, Byström E, Carnahan A, et al. Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand 2020;99(7):819-822. | es |
dc.source.bibliographicCitation | Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population-based cohort study. BMJ 2020;369:1-7. | es |
dc.source.bibliographicCitation | Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. -Pregnancy and COVID-19. Physiol Rev. 2021;101(1):303–18. | es |
dc.source.bibliographicCitation | Guleken Z, Jakubczyk P, Wiesław P, Krzysztof P, Bulut H, Öten E, et al. Characterization of Covid-19 infected pregnant women sera using laboratory indexes, vibrational spectroscopy, and machine learning classifications. Talanta. 2022;237(September 2021) | es |
dc.source.bibliographicCitation | Lombardi A, Duiella S, Piani LL, Comelli A, Ceriotti F, Oggioni M, et al. Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study. Sci Rep [Internet]. 2021;11(1):13350. Available from: https://doi.org/10.1038/s41598-021-92885-7 | es |
dc.source.bibliographicCitation | Toro F Di, Gjoka M, Lorenzo G Di, Santo D De, Seta F De, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Micriobiology Infect. 2021;27:36–46. | es |
dc.source.bibliographicCitation | Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. 2020;370. | es |
dc.source.bibliographicCitation | Crovetto F, Crispi F, Llurba E, Pascal R, Larroya M, et al. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnancy Outcomes: A Population-based Study. Clin Infect Dis. 2021;73(10):1768–75. | es |
dc.source.bibliographicCitation | Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis. Cmaj. 2021;193(16):E540–8. | es |
dc.source.bibliographicCitation | Zhang C, Chu H, Pei YV, Zhang J. Laboratory Effects of COVID-19 Infection in Pregnant Women and Their Newborns: A Systematic Review and Meta-Analysis. Front Glob Women’s Heal. 2021;2(April):1–13. | es |
dc.source.bibliographicCitation | Li Q, Chen L, Jiang H, Zheng D, Wang Y, Mei J, et al. Clinical characteristics of pregnant women infected with Coronavirus Disease 2019 in China: a nationwide case-control study. medRxiv [Internet]. 2021;2021.10.21.21265313. Available from: http://medrxiv.org/content/early/2021/10/23/2021.10.21.21265313.abstract | es |
dc.source.bibliographicCitation | Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, García-May PK, Mhatre M, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021;225(3):289.e1-289.e17 | es |
dc.source.bibliographicCitation | Henderson JT, Vesco KK, Senger CA, Thomas RG, Redmond N. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA - J Am Med Assoc. 2021;326(12):1192–206. | es |
dc.source.bibliographicCitation | Karasek D, Baer RJ, McLemore MR, Bell AJ, Blebu BE, Casey JA, et al. The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California. Lancet Reg Heal - Am [Internet]. 2021;2:100027. Available from: https://doi.org/10.1016/j.lana.2021.100027 | es |
dc.source.bibliographicCitation | Shah PS, Ye XY, Yang J, Campitelli MA. Preterm birth and stillbirth rates during the COVID-19 pandemic: A population-based cohort study. Cmaj. 2021;193(30):E1164–72. | es |
dc.source.bibliographicCitation | Bahrami R, Schwartz DA, Karimi-Zarchi M, Javaheri A, Dastgheib SA, Ferdosian F, et al. Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19. J Turkish Soc Obstet Gynecol. 2021;18(3):236–44. | es |
dc.source.bibliographicCitation | Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality among Pregnant Women with and without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817–26 | es |
dc.source.bibliographicCitation | Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet [Internet]. 2021;303(2):337–45. Available from: https://doi.org/10.1007/s00404-020-05889-5 | es |
dc.source.instname | instname:Universidad del Rosario | |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | |
dc.subject | SARS-CoV 2 | es |
dc.subject | Covid-19 | es |
dc.subject | Sepsis | es |
dc.subject | APGAR | es |
dc.subject | Ventilación mecánica | es |
dc.subject.ddc | Enfermedades | es |
dc.subject.keyword | SARS-COV 2 | es |
dc.subject.keyword | Covid-19 | es |
dc.subject.keyword | Sepsis | es |
dc.subject.keyword | Mechanic ventilation | es |
dc.subject.keyword | APGAR | es |
dc.title | Desenlaces materno-fetales en pacientes gestantes con infección confirmada por SARS COV 2 - Hospital Universitario Mayor, marzo 2020 - 2021 | es |
dc.title.TranslatedTitle | Maternal-fetal outcomes in pregnant patients with confirmed SARS COV 2 infection - Hospital Universitario Mayor, March 2020 - 2021 | es |
dc.type | masterThesis | eng |
dc.type.document | Tesis | es |
dc.type.hasVersion | info:eu-repo/semantics/acceptedVersion | |
dc.type.spa | Tesis de maestría | spa |
local.department.report | Escuela de Medicina y Ciencias de la Salud | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- DESENLACES-MATERNO-FETALES-EN-PACIENTES-GESTANTES-CON-INFECCION-CONFIRMADA-POR-SARS-COV-2---HOSPITAL-UNIVERSITARIO-MAYOR,-MARZO-2020---2021.pdf
- Tamaño:
- 623.17 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Trabajo final